David McIntosh: African Healthcare and European Partnerships in Plasma Medicine
David McIntosh, Founder and Chair of United Plasma Action, shared European Medicines Agency’s post on LinkedIn, adding:
”This welcome news must surely be a great encouragement to all who are concerned with – or about – African Healthcare matters.
I repost it here mainly for that reason.
However, a cautionary footnote is also advisable.
European Healthcare and Pharmaceuticals are well advanced, of course, and there’s much there from which others can learn, and benefit. There are some aspects of European practice, policy and folklore that are less valuable. Some are positively counter-productive.
Africa will therefore do well to approach all European partnerships with both optimism and caution.
In a specific example – the European approach to plasma-derived medicines is backward and unproductive. It would not be a good rôle model for Africa to follow.
The Continent of Europe is heavily dependent on US plasma to meet the needs of European patients.
European countries following the ‘party line’ on plasma collection/donation are all failing to meet their own patients’ needs.
None are generating any surplus to export for the benefit of others.
In the plasma medicines field, Africa should beware of Europeans bearing gifts.”
Quoting European Medicines Agency’s post:
”The African Medicines Agency (AMA) officially opened its doors in Kigali, Rwanda, marking a major milestone for strengthening regulatory systems across the continent.
The agency is committed to enhancing collaboration among National Regulatory Authorities (NRAs) across Africa and improve patients’ access to safe, quality, and efficacious medical products.
EMA, together with the European medicines regulatory network, has supported the African Union in establishing the agency through guidance, technical expertise, and financial support to help bring the African Medicines Agency to life. EMA’s support is part of the MAV plus (Manufacturing and Access to Vaccines, Medicines and Health Technologies) initiative, a Global Gateway flagship project.
In our new video, you can hear from Emer Cooke and Dr Delese Mimi Darko, leaders of their respective agencies, as they share insights into this unique partnership and the first weeks of AMA in action.”
Proceed to the video attached to the post.
Other posts featuring David McIntosh on Hemostasis Today.
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care